213 related articles for article (PubMed ID: 31044436)
1. Acute myeloid leukaemia niche regulates response to L-asparaginase.
Michelozzi IM; Granata V; De Ponti G; Alberti G; Tomasoni C; Antolini L; Gambacorti-Passerini C; Gentner B; Dazzi F; Biondi A; Coliva T; Rizzari C; Pievani A; Serafini M
Br J Haematol; 2019 Aug; 186(3):420-430. PubMed ID: 31044436
[TBL] [Abstract][Full Text] [Related]
2. In vitro efficacy of l-asparaginase in childhood acute myeloid leukaemia.
Okada S; Hongo T; Yamada S; Watanabe C; Fujii Y; Ohzeki T; Horikoshi Y; Ito T; Yazaki M; Komada Y; Tawa A
Br J Haematol; 2003 Dec; 123(5):802-9. PubMed ID: 14632770
[TBL] [Abstract][Full Text] [Related]
3. l-Asparaginase-mediated downregulation of c-Myc promotes 1,25(OH)
Song JH; Park E; Kim MS; Cho KM; Park SH; Lee A; Song J; Kim HJ; Koh JT; Kim TS
Int J Cancer; 2017 May; 140(10):2364-2374. PubMed ID: 28224619
[TBL] [Abstract][Full Text] [Related]
4. Hypersensitive reactions and antibody formation during L-asparaginase treatment of children and adults with acute leukemia.
Killander D; Dohlwitz A; Engstedt L; Franzén S; Gahrton G; Gullbring B; Holm G; Holmgren A; Höglund S; Killander A; Lockner D; Mellstedt H; Moe PJ; Palmblad J; Reizenstein P; Skårberg KO; Swedberg B; Udén AM; Wadman B; Wide L; Ahström L
Cancer; 1976 Jan; 37(1):220-8. PubMed ID: 1061636
[TBL] [Abstract][Full Text] [Related]
5. CD45RA, a specific marker for leukaemia stem cell sub-populations in acute myeloid leukaemia.
Kersten B; Valkering M; Wouters R; van Amerongen R; Hanekamp D; Kwidama Z; Valk P; Ossenkoppele G; Zeijlemaker W; Kaspers G; Cloos J; Schuurhuis GJ
Br J Haematol; 2016 Apr; 173(2):219-35. PubMed ID: 26814163
[TBL] [Abstract][Full Text] [Related]
6. CD34+CD38-CD123+ Cells Are Present in Virtually All Acute Myeloid Leukaemia Blasts: A Promising Single Unique Phenotype for Minimal Residual Disease Detection.
Al-Mawali A; Pinto AD; Al-Zadjali S
Acta Haematol; 2017; 138(3):175-181. PubMed ID: 29065396
[TBL] [Abstract][Full Text] [Related]
7. Acute Myeloid Leukaemia in Its Niche: the Bone Marrow Microenvironment in Acute Myeloid Leukaemia.
Ladikou EE; Sivaloganathan H; Pepper A; Chevassut T
Curr Oncol Rep; 2020 Feb; 22(3):27. PubMed ID: 32048054
[TBL] [Abstract][Full Text] [Related]
8. Asparagine synthetase activity in paediatric acute leukaemias: AML-M5 subtype shows lowest activity.
Dübbers A; Würthwein G; Müller HJ; Schulze-Westhoff P; Winkelhorst M; Kurzknabe E; Lanvers C; Pieters R; Kaspers GJ; Creutzig U; Ritter J; Boos J
Br J Haematol; 2000 May; 109(2):427-9. PubMed ID: 10848836
[TBL] [Abstract][Full Text] [Related]
9. Dexamethasone-mediated inhibition of Notch signalling blocks the interaction of leukaemia and mesenchymal stromal cells.
Ahmed HMM; Nimmagadda SC; Al-Matary YS; Fiori M; May T; Frank D; Patnana PK; Récher C; Schliemann C; Mikesch JH; Koenig T; Rosenbauer F; Hartmann W; Tuckermann J; Dührsen U; Lanying W; Dugas M; Opalka B; Lenz G; Khandanpour C
Br J Haematol; 2022 Feb; 196(4):995-1006. PubMed ID: 34792186
[TBL] [Abstract][Full Text] [Related]
10. The bone marrow microenvironment - Home of the leukemic blasts.
Shafat MS; Gnaneswaran B; Bowles KM; Rushworth SA
Blood Rev; 2017 Sep; 31(5):277-286. PubMed ID: 28318761
[TBL] [Abstract][Full Text] [Related]
11. A dyad of lymphoblastic lysosomal cysteine proteases degrades the antileukemic drug L-asparaginase.
Patel N; Krishnan S; Offman MN; Krol M; Moss CX; Leighton C; van Delft FW; Holland M; Liu J; Alexander S; Dempsey C; Ariffin H; Essink M; Eden TO; Watts C; Bates PA; Saha V
J Clin Invest; 2009 Jul; 119(7):1964-73. PubMed ID: 19509471
[TBL] [Abstract][Full Text] [Related]
12. Cathepsin B Is Not an Intrinsic Factor Related to Asparaginase Resistance of the Acute Lymphoblastic Leukemia REH Cell Line.
Costa IM; Effer B; Costa-Silva TA; Chen C; Ciccone MF; Pessoa A; Dos Santos CO; Monteiro G
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446393
[TBL] [Abstract][Full Text] [Related]
13. [CXCR4: a new therapeutic target of the leukaemic cell? Role of the SDF-1/CXCR4 axis in acute myeloid leukaemia].
Tavernier E; Aanei C; Solly F; Flandrin-Gresta P; Campos L; Guyotat D
Bull Cancer; 2014 Jun; 101(6):593-604. PubMed ID: 24977448
[TBL] [Abstract][Full Text] [Related]
14. IL-8 as mediator in the microenvironment-leukaemia network in acute myeloid leukaemia.
Kuett A; Rieger C; Perathoner D; Herold T; Wagner M; Sironi S; Sotlar K; Horny HP; Deniffel C; Drolle H; Fiegl M
Sci Rep; 2015 Dec; 5():18411. PubMed ID: 26674118
[TBL] [Abstract][Full Text] [Related]
15. Synergy between high-dose cytarabine and asparaginase in the treatment of adults with refractory and relapsed acute myelogenous leukemia--a Cancer and Leukemia Group B Study.
Capizzi RL; Davis R; Powell B; Cuttner J; Ellison RR; Cooper MR; Dillman R; Major WB; Dupre E; McIntyre OR
J Clin Oncol; 1988 Mar; 6(3):499-508. PubMed ID: 3162515
[TBL] [Abstract][Full Text] [Related]
16. Acute myeloid leukaemia niche regulates response to L-asparaginase.
Kaspers GJL
Br J Haematol; 2019 Aug; 186(3):397-399. PubMed ID: 31020655
[No Abstract] [Full Text] [Related]
17. Antibody therapy for acute myeloid leukaemia.
Gasiorowski RE; Clark GJ; Bradstock K; Hart DN
Br J Haematol; 2014 Feb; 164(4):481-95. PubMed ID: 24321020
[TBL] [Abstract][Full Text] [Related]
18. Bone Marrow Microenvironment as a Source of New Drug Targets for the Treatment of Acute Myeloid Leukaemia.
Skelding KA; Barry DL; Theron DZ; Lincz LF
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614005
[TBL] [Abstract][Full Text] [Related]
19. Influence of lysosomal protease sensitivity in the immunogenicity of the antitumor biopharmaceutical asparaginase.
Rodrigues MAD; Pimenta MV; Costa IM; Zenatti PP; Migita NA; Yunes JA; Rangel-Yagui CO; de Sá MM; Pessoa A; Costa-Silva TA; Toyama MH; Breyer CA; de Oliveira MA; Santiago VF; Palmisano G; Barbosa CMV; Hebeda CB; Farsky SHP; Monteiro G
Biochem Pharmacol; 2020 Dec; 182():114230. PubMed ID: 32979352
[TBL] [Abstract][Full Text] [Related]
20. Multiple adaptive mechanisms affect asparagine synthetase substrate availability in asparaginase-resistant MOLT-4 human leukaemia cells.
Aslanian AM; Kilberg MS
Biochem J; 2001 Aug; 358(Pt 1):59-67. PubMed ID: 11485552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
